![Bhupender Raj Wadhwa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bhupender Raj Wadhwa
Director/Board Member at
BLUE COAST HOTELS LIMITED
Profile
Bhupender Raj Wadhwa is currently serving as a Director at Dr. Morepen Ltd., Tanishq International Pvt Ltd., and The Institute of Chartered Accountants of India.
He is also an Independent Non-Executive Director at Blue Coast Hotels Ltd. and an Independent Director at Star Dream Property & Developers Pvt Ltd. Previously, he held the position of Independent Non-Executive Director at Morepen Laboratories Ltd. from 2005 to 2024.
Bhupender Raj Wadhwa active positions
| Companies | Position | Start |
|---|---|---|
| BLUE COAST HOTELS LIMITED | Director/Board Member | 03/09/2024 |
Star Dream Property & Developers Pvt Ltd. | Director/Board Member | 04/09/2024 |
Tanishq International Pvt Ltd.
 Tanishq International Pvt Ltd. TextilesProcess Industries Manufactures textiles | Director/Board Member | - |
The Institute of Chartered Accountants of India
 The Institute of Chartered Accountants of India Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Dr. Morepen Ltd.
 Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | Director/Board Member | - |
Former positions of Bhupender Raj Wadhwa
| Companies | Position | End |
|---|---|---|
| MOREPEN LABORATORIES LIMITED | Director/Board Member | 18/09/2024 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Morepen Laboratories Ltd.
 Morepen Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures generic drugs and pharmaceutical formulations | Health Technology |
Blue Coast Hotels Ltd.
 Blue Coast Hotels Ltd. Hotels/Resorts/Cruise linesConsumer Services Engages in the hotel business | Consumer Services |
The Institute of Chartered Accountants of India
The Institute of Chartered Accountants of India Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dr. Morepen Ltd.
Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | |
Star Dream Property & Developers Pvt Ltd. | |
Tanishq International Pvt Ltd.
Tanishq International Pvt Ltd. TextilesProcess Industries Manufactures textiles | Process Industries |
- Stock Market
- Insiders
- Bhupender Raj Wadhwa
